AVCNF
Avicanna Inc.·Healthcare
0.12
4.464%(+0.01)
Close PriceLast Updated: — ET
52W L: $0.1052W H: $0.24
AVCNF NEWS
globenewswire.com
6d ago
ThreeD Capital Inc. Issues Early Warning Report in Connection with Disposition of Securities of Avicanna Inc.
TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that through a series of transactions ending in recent weeks (the “Dispositions”), ThreeD disposed of ownership and control of an aggregate of 977,000 common shares (the “Subject Shares”) of Avicanna Inc. (the “Company” or “AVCN”). The Subject Shares represented approximately 0.8% of all issued and outstanding common shares of AVCN. As a result of the Dispositions, the percentage ownership held by ThreeD and Sheldon Inwentash (the “Joint Actor”) decreased by greater than 2%, on a partially diluted basis, from the last early warning report filed.
seekingalpha.com
6d ago
Avicanna Inc. (AVCN:CA) Q4 2025 Earnings Call Transcript
Avicanna Inc. (AVCN:CA) Q4 2025 Earnings Call Transcript
globenewswire.com
Apr 6
Avicanna Announces Changes to its Board of Directors
TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announces effective Thursday April 1, 2026 the resignation of John McVicar and pleased to announce the appointment of Mr. Ozgur Kilic to the Board of Directors of the Company.
globenewswire.com
Apr 1
Avicanna Reports Full Year 2025 Audited Financial Statements
Achieved positive adjusted EBITDA in Q4 2025 and near break-even $(0.29) million for the full year Advancements across business units, R&D, and clinical development to support scale and international growth
globenewswire.com
Mar 26
Avicanna Subsidiary SMGH Completes First Commercial Export to Australia
This marks the first commercial export of organic certified flower for SMGH The export represents the 21 st market for SMGH and 24 th market for all Avicanna products
globenewswire.com
Mar 16
Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial
New randomized controlled trial to evaluate dose-dependent effects of oral THC on anxiety and stress using Avicanna's proprietary capsules New randomized controlled trial to evaluate dose-dependent effects of oral THC on anxiety and stress using Avicanna's proprietary capsules
